Health-Related Quality of Life and Psychiatric Morbidity at Follow-up After Catheter Ablation in Children with Supraventricular Tachycardia
Psychiatry and Clinical Psychopharmacology · 12.08.2026 · 36 (4) · 373-381
DOI: 10.65801/pcp.3459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Psychopharmacology, online erschienen am 12.08.2026. Verfasst von Tuğba Doğaç und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, Malatya Turgut Özal University, Malatya, Türkiye. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
This study aimed to evaluate health-related quality of life (HRQoL) and psychiatric outcomes in children and adolescents with supraventricular tachycardia (SVT) during the post-ablation follow-up period.
Methods
This retrospective–prospective observational cohort study included pediatric patients who underwent successful catheter ablation for supraventricular tachycardia. Clinical and procedural data were collected retrospectively. Pre-ablation HRQoL data were obtained from either documented preprocedural assessments or caregiver recall when records were unavailable. Psychiatric interviews and post-ablation HRQoL assessments were conducted prospectively during a single follow-up evaluation.
Results
A total of 59 pediatric patients participated in the follow-up evaluation and were included in the study; the median age was 13.0 years (Q1–Q3, 10.0–15.0). Depending on the HRQoL domain, paired preand post-ablation data were available for 53 or 54 participants. Follow-up scores for physical, emotional, social, and school functioning were higher than the retrospectively obtained pre-ablation reference scores (all p < .001; Bonferroni-adjusted significance threshold, p < .0125). At follow-up, at least 1 DSM-5 psychiatric diagnosis was identified in 18 participants (30.5%), most commonly anxiety and depressive disorders. Seven of these participants had 2 or more concurrent psychiatric diagnoses.
Conclusion
Pediatric patients had higher HRQoL scores at post-ablation follow-up, and 30.5% met criteria for at least 1 psychiatric diagnosis. The HRQoL comparisons should be interpreted cautiously because baseline data were obtained from a combination of medical records and caregiver recall, informants were not fully standardized across assessment periods, and the exact interval between ablation and follow-up could not be reliably reconstructed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Child and Adolescent Psychiatry, Malatya Turgut Özal University, Malatya, Türkiye.
- Department of Pediatric Cardiology, İnönü University Faculty of Medicine, Malatya, Türkiye.
- Department of Cardiology, Malatya Training and Research Hospital, Malatya, Türkiye.
- Department of Child and Adolescent Psychiatry, Malatya Training and Research Hospital, Malatya, Türkiye.
ORCID-Profile: Tuğba Doğaç, Özlem Elkıran, Serdar Akın Maraş, Mehmet Öncül, Özlem Doğan
Zitieren
APA
Doğaç, T., Elkıran, Ö., Maraş, S. A., Öncül, M., & Doğan, Ö. (2026). Health-Related Quality of Life and Psychiatric Morbidity at Follow-up After Catheter Ablation in Children with Supraventricular Tachycardia. Psychiatry and Clinical Psychopharmacology, 36(4), 373-381. https://doi.org/10.65801/pcp.3459
Vancouver
Doğaç T, Elkıran Ö, Maraş SA, Öncül M, Doğan Ö. Health-Related Quality of Life and Psychiatric Morbidity at Follow-up After Catheter Ablation in Children with Supraventricular Tachycardia. Psychiatry and Clinical Psychopharmacology. 2026;36(4):373-381. doi:10.65801/pcp.3459
BibTeX
@article{Doa2026,
author = {Doğaç, Tuğba and Elkıran, Özlem and Maraş, Serdar Akın and Öncül, Mehmet and Doğan, Özlem},
title = {Health-Related Quality of Life and Psychiatric Morbidity at Follow-up After Catheter Ablation in Children with Supraventricular Tachycardia},
journal = {Psychiatry and Clinical Psychopharmacology},
year = {2026},
volume = {36},
number = {4},
pages = {373--381},
doi = {10.65801/pcp.3459}
}
EUVIMED